- Radboud Repository
- →
- Browsing by Author
JavaScript is disabled for your browser. Some features of this site may not work without it.
Browsing by Author "Jong, D.J. de"
Now showing items 1-50 of 154
-
-
Vedolizumab for Inflammatory Bowel Disease: Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, A Nationwide Prospective Observational Cohort Study: ICC Registry - Vedolizumab ; Woude, C.J. van der; Dijkstra, G.; Meulen-de Jong, A.E. van der; Oldenburg, B.; Boer, N.K. de; Löwenberg, M.; Srivastava, N.; Bodelier, A.G.L.; West, R.L.; et al.2020, Article / Letter to editor (Clinical Pharmacology and Therapeutics, vol. 107, (2020), pp. 1189-1199)
sine al.
-
Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn's disease patients with prior failure to anti-TNF treatment ; Woude, C.J. van der; Dijkstra, G.; Meulen-de Jong, A.E. van der; Löwenberg, M.; Boer, N.K. de; Oldenburg, B.; Srivastava, N.; Jansen, J.M; Bodelier, A.G.L.; et al.2020, Article / Letter to editor (Alimentary Pharmacology & Therapeutics, vol. 52, (2020), pp. 123-134)
sine al.
-
Limited added value of laboratory monitoring in thiopurine maintenance monotherapy in inflammatory bowel disease patients Kreijne, J.E.; Vries, A.C.M. de; Veer, R.C. de; Bouma, G.; Dijkstra, G.; Voskuil, M.D.; West, R.; Moorsel, S.A.W. van; ; Boer, N.K. de; et al.2020, Article / Letter to editor (Alimentary Pharmacology & Therapeutics, vol. 51, (2020), pp. 1353-1364)
sine al.
-
-
-
Genotype-Guided Thiopurine Dosing Does not Lead to Additional Costs in Patients With Inflammatory Bowel Disease Sluiter, R.L.; ; ; ; Guchelaar, H.J.; Derijks, L.J.; ; ; ; ; et al.2019, Article / Letter to editor (Journal of Crohn's and Colitis, vol. 13, iss. 7, (2019), pp. 838-845)
sine al.
-
-
-
-
-
Patients' beliefs about medicine are associated with early thiopurine discontinuation in patients with inflammatory bowel diseases Broekman, M.M.T.J.; ; ; ; ; Klungel, O.H.; ; Wong, D.R.; Hooymans, P.M.; Guchelaar, H.J.; et al.2018, Article / Letter to editor (European Journal of Gastroenterology & Hepatology, vol. 30, iss. 2, (2018), pp. 167-173)
sine al.
-
IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes Momozawa, Y.; Dmitrieva, J.; Theatre, E.; Deffontaine, V.; Rahmouni, S.; Charloteaux, B.; Crins, F.; Docampo, E.; Elansary, M.; Gori, A.S.; et al.2018, Article / Letter to editor (Nature Communications, vol. 9, iss. 1, (2018), pp. 2427)
sine al.
-
Genetic deficiency of NOD2 confers resistance to invasive aspergillosis Gresnigt, M.S.; Cunha, C.; ; Goncalves, S.M.; Malireddi, R.K.S.; ; Lubbers, R.; ; Rasid, O.; Jouvion, G.; et al.2018, Article / Letter to editor (Nature Communications, vol. 9, iss. 1, (2018), article 2636)
sine al.
-
Genomic and Expression Analyses Identify a Disease-Modifying Variant for Fibrostenotic Crohn's Disease Visschedijk, M.C.; Spekhorst, L.M.; Cheng, S.C.; Loo, E.S. van; Jansen, B.H.D.; Blokzijl, T.; Kil, H.; ; Pierik, M.; Maljaars, J.; et al.2018, Article / Letter to editor (Journal of Crohn's and Colitis, vol. 12, iss. 5, (2018), pp. 582-588)
sine al.
-
-
Risk factors for thiopurine-induced myelosuppression and infections in inflammatory bowel disease patients with a normal TPMT genotype Broekman, M.M.T.J.; ; ; ; Klungel, O.H.; ; Hooymans, P.M.; Guchelaar, H.J.; ; Derijks, L.J.; et al.2017, Article / Letter to editor (Alimentary Pharmacology & Therapeutics, vol. 46, iss. 10, (2017), pp. 953-963)
sine al.
-
More Dose-dependent Side Effects with Mercaptopurine over Azathioprine in IBD Treatment Due to Relatively Higher Dosing Broekman, M.M.T.J.; ; ; ; Wong, D.R.; ; Klungel, O.H.; Hooymans, P.M.; Guchelaar, H.J.; ; et al.2017, Article / Letter to editor (Inflammatory Bowel Diseases, vol. 23, iss. 10, (2017), pp. 1873-1881)
sine al.
-
-
Early Assessment of Thiopurine Metabolites Identifies Patients at Risk of Thiopurine-induced Leukopenia in Inflammatory Bowel Disease Wong, D.R.; ; ; Derijks, L.J.; ; Klungel, O.H.; ; ; Guchelaar (LUMC), H.J.; ; et al.2017, Article / Letter to editor (Journal of Crohn's and Colitis, vol. 11, iss. 2, (2017), pp. 175-184)
sine al.
-
Early prediction of thiopurine-induced hepatotoxicity in inflammatory bowel disease Wong, D.R.; ; Derijks, L.J.; ; ; Klungel, O.H.; ; ; Guchelaar (LUMC), H.J.; ; et al.2017, Article / Letter to editor (Alimentary Pharmacology & Therapeutics, vol. 45, iss. 3, (2017), pp. 391-402)
sine al.
-
-
-
Smoking is Associated with Higher Disease-related Costs and Lower Health-related Quality of Life in Inflammatory Bowel Disease Severs, M.; Mangen, M.J.; Valk, M.E. van der; Fidder, H.H.; Dijkstra, G.; Have, M. van der; Bodegraven, A.A. van; ; Woude, C.J. van der; Romberg-Camps, M.J.; et al.2017, Article / Letter to editor (Journal of Crohn's and Colitis, vol. 11, iss. 3, (2017), pp. 342-352)
sine al.
-
Clinical Predictors of Future Nonadherence in Inflammatory Bowel Disease Severs, M.; Mangen, M.J.; Fidder, H.H.; Valk, M.E. van der; Have, M. van der; Bodegraven, A.A. van; Clemens, C.H.; Dijkstra, G.; Jansen, J.M.; ; et al.2017, Article / Letter to editor (Inflammatory Bowel Diseases, vol. 23, iss. 9, (2017), pp. 1568-1576)
sine al.
-
Cohort profile: design and first results of the Dutch IBD Biobank: a prospective, nationwide biobank of patients with inflammatory bowel disease Spekhorst, L.M.; Imhann, F.; Festen, E.A.M.; Bodegraven, A.A. van; Boer, N.K. de; Bouma, G.; Fidder, H.H.; d'Haens, G.; ; Hommes, D.W.; et al.2017, Article / Letter to editor (BMJ Open, vol. 7, iss. 11, (2017), article e016695)
sine al.
-
-
The Prevalence of Nodular Regenerative Hyperplasia in Inflammatory Bowel Disease Patients Treated with Thioguanine Is Not Associated with Clinically Significant Liver Disease Asseldonk, D.P. van; Jharap, B.; Verheij, J.; Hartog, G. den; Westerveld, D.B.; Becx, M.C.; Russel, M.G.; Engels, L.G.; ; Witte, B.I.; et al.2016, Article / Letter to editor (Inflammatory Bowel Diseases, vol. 22, iss. 9, (2016), pp. 2112-2120)
sine al.
-
Pooled Resequencing of 122 Ulcerative Colitis Genes in a Large Dutch Cohort Suggests Population-Specific Associations of Rare Variants in MUC2 Visschedijk, M.C.; Alberts, R.; Mucha, S.; Deelen, P.; ; Pierik, M.; Spekhorst, L.M.; Imhann, F.; Jong, A E F de; Woude, C.J. van der; et al.2016, Article / Letter to editor (PLoS One, vol. 11, iss. 8, (2016), article e0159609)
sine al.
-
-
Smoking is Associated With Extra-intestinal Manifestations in Inflammatory Bowel Disease Severs, M.; Erp, S.J. van; Valk, M.E. van der; Mangen, M.J.; Fidder, H.H.; Have, M. van der; Bodegraven, A.A. van; ; Woude, C.J. van der; Romberg-Camps, M.J.; et al.2016, Article / Letter to editor (Journal of Crohn's and Colitis, vol. 10, iss. 4, (2016), pp. 455-461)
sine al.
-
Evolution of Costs of Inflammatory Bowel Disease over Two Years of Follow-Up Valk, M. van der; Mangen, M.J.; Severs, M.; Have, M. van der; Dijkstra, G.; Bodegraven, A.A. van; Fidder, H.H.; ; Woude, C.J. van der; Romberg-Camps, M.J.; et al.2016, Article / Letter to editor (PLoS One, vol. 11, iss. 4, (2016), article e0142481)
sine al.
-
Impaired Gastric Cancer Survival in Patients with Inflammatory Bowel Disease Nissen, L.H.; Assendorp, E.L.; Post, R.S. van der; Derikx, L.A.; ; ; Pierik, M.; Heuvel, T. van den; Verhoeven, R.; ; et al.2016, Article / Letter to editor (Journal of Gastrointestinal and Liver Diseases, vol. 25, iss. 4, (2016), pp. 431-440)
sine al.
-
Rewiring cellular metabolism via the AKT/mTOR pathway contributes to host defence against Mycobacterium tuberculosis in human and murine cells Lachmandas, E.L.; Beigier-Bompadre, M.; Cheng, S.C.; ; ; Wang, X.; Ammerdorffer, A.; Boutens, L.; ; Kanneganti, T.D.; et al.2016, Article / Letter to editor (European Journal of Immunology, vol. 46, iss. 11, (2016), pp. 2574-2586)
sine al.
-
Self-reported disability in patients with inflammatory bowel disease largely determined by disease activity and illness perceptions Have, M. van der; Fidder, H.H.; Leenders, M.; Kaptein, A.A.; Valk, M.E. van der; Bodegraven, A.A. van; Dijkstra, G.; ; Pierik, M.; Ponsioen, C.Y.; et al.2015, Article / Letter to editor (Inflammatory Bowel Diseases, vol. 21, iss. 2, (2015), pp. 369-377)
sine al.
-
Recognition of Coxiella burnetii by Toll-like Receptors and Nucleotide-Binding Oligomerization Domain-like Receptors ; Schoffelen, T.; Gresnigt, M.S.; ; ; ; Kanneganti, T.D.; ; ; Roest, H.J.; et al.2015, Article / Letter to editor (The Journal of Infectious Diseases, vol. 211, iss. 6, (2015), pp. 978-987)
sine al.
-
Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease ; ; ; Derijks, L.J.; ; Wong, D.R.; Klungel, O.H.; ; Hooymans, P.M.; Peters, W.H.; et al.2015, Article / Letter to editor (Gastroenterology, vol. 149, iss. 4, (2015), pp. 907-917.e7)
sine al.
-
-
Comparison of Costs and Quality of Life in Ulcerative Colitis Patients with an Ileal Pouch-Anal Anastomosis, Ileostomy and Anti-TNFalpha Therapy Valk, M.E. van der; Mangen, M.J.; Severs, M.; Have, M. van der; Dijkstra, G.; Bodegraven, A.A. van; Fidder, H.H.; ; Pierik, M.; Woude, C.J. van der; et al.2015, Article / Letter to editor (Journal of Crohn's and Colitis, vol. 9, iss. 11, (2015), pp. 1016-1023)
sine al.
-
-
-
-
Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease Jharap, B.; Boer, N.K. de; Stokkers, P.; Hommes, D.W.; Oldenburg, B.; Dijkstra, G.; Woude, C.J. van der; ; Mulder, C.J.; Elburg, R.M. van; et al.2014, Article / Letter to editor (Gut, vol. 63, iss. 3, (2014), pp. 451-457)
sine al.
-
Myosin IXb variants and their pivotal role in maintaining the intestinal barrier: A study in Crohn's disease Prager, M.; Durmus, T.; Buttner, J.; Molnar, T.; ; ; Baumgart, D.C.; Sturm, A.; Farkas, K.; Witt, H.; et al.2014, Article / Letter to editor (Scandinavian Journal of Gastroenterology, vol. 49, iss. 10, (2014), pp. 1191-1200)
sine al.
-
Effect of aging on healthcare costs of inflammatory bowel disease: a glimpse into the future Have, M. van der; Mangen, M.J.; Valk, M.E. van der; Smeets, H.M.; Bodegraven, A. van; Dijkstra, G.; Fidder, H.H.; ; Pierik, M.; Ponsioen, C.Y.; et al.2014, Article / Letter to editor (Inflammatory Bowel Diseases, vol. 20, iss. 4, (2014), pp. 637-645)
sine al.
-
Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFalpha therapy: results from the COIN study Valk, M.E. van der; Mangen, M.J.; Leenders, M.; Dijkstra, G.; Bodegraven, A.A. van; Fidder, H.H.; ; Pierik, M.; Woude, C.J. van der; Romberg-Camps, M.J.; et al.2014, Article / Letter to editor (Gut, vol. 63, iss. 1, (2014), pp. 72-79)
sine al.
-
Risk factors of work disability in patients with inflammatory bowel disease - A Dutch nationwide web-based survey: Work disability in inflammatory bowel disease Valk, M.E. van der; Mangen, M.J.; Leenders, M.; Dijkstra, G.; Bodegraven, A.A. van; Fidder, H.H.; ; Pierik, M.; Woude, C.J. van der; Romberg-Camps, M.J.; et al.2014, Article / Letter to editor (Journal of Crohn'S and Colitis, vol. 8, iss. 7, (2014), pp. 590-597)
sine al.
-
-
-
Prior colorectal neoplasia is associated with increased risk of ileoanal pouch neoplasia in patients with inflammatory bowel disease Derikx, L.A.A.P.; ; ; ; Ponsioen, C.Y.; Oldenburg, B.; Jong, A.E. de; Dijkstra, G.; ; ; et al.2014, Article / Letter to editor (Gastroenterology, vol. 146, iss. 1, (2014), pp. 119-128 e1)
sine al.
Now showing items 1-50 of 154
Upload Full Text